First name
Karen
Middle name
M
Last name
Wilson

Title

Patient Characteristics Associated with Differences in Admission Frequency for Diabetic Ketoacidosis in United States Children's Hospitals.

Year of Publication

2016

Number of Pages

104-10

Date Published

2016 Apr

ISSN Number

1097-6833

Abstract

OBJECTIVES: To determine across and within hospital differences in the predictors of 365-day admission frequency for diabetic ketoacidosis (DKA) in children at US children's hospitals.

STUDY DESIGN: Multicenter retrospective cohort analysis of 12 449 children 2-18 years of age with a diagnosis of DKA in 42 US children's hospitals between 2004 and 2012. The main outcome of interest was the maximum number of DKA admissions experienced by each child within any 365-day interval during a 5-year follow-up period. The association between patient characteristics and the maximum number of DKA admissions within a 365-day interval was examined across and within hospitals.

RESULTS: In the sample, 28.3% of patients admitted for DKA experienced at least 1 additional DKA admission within the following 365 days. Across hospitals, patient characteristics associated with increasing DKA admission frequency were public insurance (OR 1.97, 95% CI 1.71-2.26), non-Hispanic black race (OR 2.40, 95% CI 2.02-2.85), age ≥12 (OR 1.98, 95% CI 1.7-2.32), female sex (OR 1.41, 95% CI 1.29-1.55), and mental health comorbidity (OR 1.36, 95% CI 1.13-1.62). Within hospitals, non-Hispanic black race was associated with higher odds of 365-day admission in 59% of hospitals, and public insurance was associated with higher odds in 56% of hospitals. Older age, female sex, and mental health comorbidity were associated with higher odds of 365-day admission in 42%, 29%, and 15% of hospitals, respectively.

CONCLUSIONS: Across children's hospitals, certain patient characteristics are associated with more frequent DKA admissions. However, these factors are not associated with increased DKA admission frequency for all hospitals.

DOI

10.1016/j.jpeds.2015.12.015

Alternate Title

J. Pediatr.

PMID

26787380

Title

Variation in Dexamethasone Dosing and Use Outcomes for Inpatient Croup.

Year of Publication

2021

Date Published

2021 Dec 01

ISSN Number

2154-1671

Abstract

<p><strong>OBJECTIVES: </strong>Evaluate the association between dexamethasone dosing and outcomes for children hospitalized with croup.</p>

<p><strong>METHODS: </strong>This study was nested within a multisite prospective cohort study of children aged 6 months to 6 years admitted to 1 of 5 US children's hospitals between July 2014 and June /2016. Multivariable linear and logistic mixed-effects regression models were used to examine the association between the number of dexamethasone doses (1 vs &gt;1) and outcomes (length of stay [LOS], cost, and 30-day same-cause reuse). All multivariable analyses included a site-specific random effect to account for clustering within hospital and were adjusted for age, sex, race and ethnicity, presenting severity, medical complexity, insurance, caregiver education, and hospital. In cost analyses, we controlled for LOS.</p>

<p><strong>RESULTS: </strong>Among 234 children hospitalized with croup, patient characteristics did not differ by number of doses. The proportion receiving &gt;1 dose varied by hospital (range 27.9%-57.1%). In adjusted analyses, &gt;1 dose was not associated with same-cause reuse (odds ratio 0.87 [95% confidence interval (CI): 0.26 to 2.95]) but was associated with 45% longer LOS (relative risk = 1.45 [95% CI: 1.30 to 1.62]). When we controlled for LOS, &gt;1 dose was not associated with differential cost ($-31.2 [95% CI $-424.4 to $362.0]). Eighty-two (35%) children received dexamethasone before presentation.</p>

<p><strong>CONCLUSIONS: </strong>We found significant interhospital variation in dexamethasone dosing and LOS. When we controlled for severity on presentation, &gt;1 dexamethasone dose was associated with longer LOS but not reuse. Although incomplete adjustment for severity is one possible explanation, some providers may routinely keep children hospitalized to administer multiple dexamethasone doses.</p>

DOI

10.1542/hpeds.2021-005854

Alternate Title

Hosp Pediatr

PMID

34846064

Title

Pediatric Respiratory Illness Measurement System (PRIMES) Scores and Outcomes.

Year of Publication

2019

Date Published

2019 Jul 26

ISSN Number

1098-4275

Abstract

<p><strong>BACKGROUND AND OBJECTIVES: </strong>The Pediatric Respiratory Illness Measurement System (PRIMES) generates condition-specific composite quality scores for asthma, bronchiolitis, croup, and pneumonia in hospital-based settings. We sought to determine if higher PRIMES composite scores are associated with improved health-related quality of life, decreased length of stay (LOS), and decreased reuse.</p>

<p><strong>METHODS: </strong>We conducted a prospective cohort study of 2334 children in 5 children's hospitals between July 2014 and June 2016. Surveys administered on admission and 2 to 6 weeks postdischarge assessed the Pediatric Quality of Life Inventory (PedsQL). Using medical records data, 3 PRIMES scores were calculated (0-100 scale; higher scores = improved adherence) for each condition: an overall composite (including all quality indicators for the condition), an overuse composite (including only indicators for care that should not be provided [eg, chest radiographs for bronchiolitis]), and an underuse composite (including only indicators for care that should be provided [eg, dexamethasone for croup]). Multivariable models assessed relationships between PRIMES composite scores and (1) PedsQL improvement, (2) LOS, and (3) 30-day reuse.</p>

<p><strong>RESULTS: </strong>For every 10-point increase in PRIMES overuse composite scores, LOS decreased by 8.8 hours (95% confidence interval [CI] -11.6 to -6.1) for bronchiolitis, 3.1 hours (95% CI -5.5 to -1.0) for asthma, and 2.0 hours (95% CI -3.9 to -0.1) for croup. Bronchiolitis overall composite scores were also associated with shorter LOS. PRIMES composites were not associated with PedsQL improvement or reuse.</p>

<p><strong>CONCLUSIONS: </strong>Better performance on some PRIMES condition-specific composite measures is associated with decreased LOS, with scores on overuse quality indicators being a primary driver of this relationship.</p>

DOI

10.1542/peds.2019-0242

Alternate Title

Pediatrics

PMID

31350359

Title

Home Smoke Exposure and Health-Related Quality of Life in Children with Acute Respiratory Illness.

Year of Publication

2019

Number of Pages

212-217

Date Published

2019 Apr

ISSN Number

1553-5606

Abstract

<p><strong>OBJECTIVE: </strong>This study aims to assess whether secondhand smoke (SHS) exposure has an impact on health-related quality of life (HRQOL) in children with acute respiratory illness (ARI).</p>

<p><strong>METHODS: </strong>This study was nested within a multicenter, prospective cohort study of children (two weeks to 16 years) with ARI (emergency department visits for croup and hospitalizations for croup, asthma, bronchiolitis, and pneumonia) between July 1, 2014 and June 30, 2016. Subjects were surveyed upon enrollment for sociodemographics, healthcare utilization, home SHS exposure (0 or ≥1 smoker in the home), and child HRQOL (Pediatric Quality of Life Physical Functioning Scale) for both baseline health (preceding illness) and acute illness (on admission). Data on insurance status and medical complexity were collected from the Pediatric Hospital Information System database. Multivariable linear mixed regression models examined associations between SHS exposure and HRQOL.</p>

<p><strong>RESULTS: </strong>Home SHS exposure was reported in 728 (32%) of the 2,309 included children. Compared with nonexposed children, SHS-exposed children had significantly lower HRQOL scores for baseline health (mean difference -3.04 [95% CI -4.34, -1.74]) and acute illness (-2.16 [-4.22, -0.10]). Associations were strongest among children living with two or more smokers. HRQOL scores were lower among SHS-exposed children for all four conditions but only significant at baseline for bronchiolitis (-2.94 [-5.0, -0.89]) and pneumonia (-4.13 [-6.82, -1.44]) and on admission for croup (-5.71 [-10.67, -0.75]).</p>

<p><strong>CONCLUSIONS: </strong>Our study demonstrates an association between regular SHS exposure and decreased HRQOL with a dose-dependent response for children with ARI, providing further evidence of the negative impact of SHS.</p>

DOI

10.12788/jhm.3164

Alternate Title

J Hosp Med

PMID

30933671

Title

What is new in electronic-cigarettes research?

Year of Publication

2019

Date Published

2019 Feb 11

ISSN Number

1531-698X

Abstract

<p><strong>PURPOSE OF REVIEW: </strong>Electronic cigarettes (e-cigarettes) and other vaping devices have seen extraordinary growth in use in the past 10 years, and companies are accelerating their development of new products and marketing efforts. In turn, researchers have increased their efforts to determine how e-cigarettes affect health, how marketing these products impacts adolescents and how the use of e-cigarettes may affect adolescents' use of other tobacco products. Products like Juul were not on the market 2 years ago; thus, frequent updates on the topic are essential.</p>

<p><strong>RECENT FINDINGS: </strong>Studies have begun to demonstrate that users of the newer pod systems are exposed to high levels of nicotine, as well as other chemicals. These products are highly marketed, with a strong emphasis on how adolescents can use them surreptitiously. This is concerning to researchers, and other studies have continued to demonstrate that teens who use e-cigarettes are more likely to go on to use combusted tobacco. Further research has also failed to demonstrate that e-cigarettes are useful for people wishing to quit smoking combusted tobacco.</p>

<p><strong>SUMMARY: </strong>E-cigarettes and vaping systems are not safe products and should not be used by adolescents.</p>

DOI

10.1097/MOP.0000000000000741

Alternate Title

Curr. Opin. Pediatr.

PMID

30762705

Title

Association of Weekend Admission and Weekend Discharge with Length of Stay and 30-Day Readmission in Children's Hospitals.

Year of Publication

2018

Date Published

2018 10 31

ISSN Number

1553-5606

Abstract

<p><strong>BACKGROUND: </strong>Worse outcomes among adults presenting for/receiving care on weekends (ie, "the weekend effect") have been observed for many diseases. However, little is known about the overall impact of the weekend effect in hospitalized children.</p>

<p><strong>OBJECTIVE: T</strong>o determine the association between weekend admission and length of stay (LOS) and between weekend discharge and 30-day all-cause readmission.</p>

<p><strong>METHODS: </strong>We conducted a retrospective, cross-sectional study of children hospitalized between October 1, 2014 and September 30, 2015 using the Pediatric Health Information System. Birth hospitalizations and planned procedures were excluded. We used generalized linear mixed modeling to assess the independent association between weekend admission and LOS and weekend discharge and readmission risk.</p>

<p><strong>RESULTS: </strong>Among 390,745 hospitalizations across 43 hospitals, the median LOS was 41 hours (interquartile range [IQR] 24-71) and the 30-day readmission rate was 8.2% (IQR 7.2-9.4). We observed no association between weekend admission and LOS (adjusted LOS [95% CI: weekend 63.70 [61.01-66.52] hours vs weekday 63.40 [60.73-66.19] hours, P = .112). Weekend discharge was associated with slightly increased odds of readmission compared with weekday discharge (adjusted probability of readmission [95% CI]: weekend 0.13 [0.12-0.13] versus weekday 0.11 [0.11-0.12], P &lt; .001) but was variable among individual hospitals. Patient characteristics (ie, number of chronic conditions) were more strongly associated with LOS and readmission risk than weekend admission or discharge.</p>

<p><strong>CONCLUSIONS: </strong>Patient-level factors (ie, clinical and demographic characteristics) are more indicative of longer LOS and readmission risk than weekend admissions or discharges. The overall impact of the weekend effect across children's hospitals was minimal.</p>

DOI

10.12788/jhm.3085

Alternate Title

J Hosp Med

PMID

30379138

Title

Impact of Discharge Components on Readmission Rates for Children Hospitalized with Asthma.

Year of Publication

2018

Number of Pages

175-181.e2

Date Published

2018 Apr

ISSN Number

1097-6833

Abstract

<p><strong>OBJECTIVES: </strong>To describe hospital-based asthma-specific discharge components at children's hospitals and determine the association of these discharge components with pediatric asthma readmission rates.</p>

<p><strong>STUDY DESIGN: </strong>This is a multicenter retrospective cohort study of pediatric asthma hospitalizations in 2015 at children's hospitals participating in the Pediatric Health Information System. Children ages 5 to 17 years were included. An electronic survey assessing 13 asthma-specific discharge components was sent to quality leaders at all 49 hospitals. Correlations of combinations of asthma-specific discharge components and adjusted readmission rates were calculated.</p>

<p><strong>RESULTS: </strong>The survey response rate was 92% (45 of 49 hospitals). Thirty-day and 3-month adjusted readmission rates varied across hospitals, ranging from 1.9% to 3.9% for 30-day readmissions and 5.7% to 9.1% for 3-month readmissions. No individual or combination discharge components were associated with lower 30-day adjusted readmission rates. The only single-component significantly associated with a lower rate of readmission at 3 months was having comprehensive content of education (P &lt; .029). Increasing intensity of discharge components in bundles was associated with reduced adjusted 3-month readmission rates, but this did not reach statistical significance. This was seen in a 2-discharge component bundle including content of education and communication with the primary medical doctor, as well as a 3-discharge component bundle, which included content of education, medications in-hand, and home-based environmental mitigation.</p>

<p><strong>CONCLUSIONS: </strong>Children's hospitals demonstrate a range of asthma-specific discharge components. Although we found no significant associations for specific hospital-level discharge components and asthma readmission rates at 30 days, certain combinations of discharge components may support hospitals to reduce healthcare utilization at 3 months.</p>

DOI

10.1016/j.jpeds.2017.11.062

PMID

29395170

Title

Tobacco Control and Treatment for the Pediatric Clinician: Practice, Policy, and Research Updates.

Year of Publication

2017

Date Published

2017 Jan 06

ISSN Number

1876-2867

Abstract

<p>Tobacco use is the leading cause of preventable death in the United States, and exposure to tobacco smoke harms children from conception forward. There is no safe level of tobacco exposure. While overall smoking rates have declined, the advent of new products, such as electronic cigarettes, threatens to perpetuate nicotine addiction without clear health benefits. In addition to reviewing traditional and new tobacco products, we discuss the unique role that pediatricians should play in tobacco treatment and control efforts. New policies and technologies can empower pediatric clinicians and pediatric healthcare systems to help parent smokers quit, and new policies outside of the healthcare setting may help prevent smoking initiation as well as improve cessation treatments. Future research is needed to continue to study both the consequences of tobacco use and exposure as well as the best ways to help patients and parents stop tobacco use.</p>

DOI

10.1016/j.acap.2016.12.010

Alternate Title

Acad Pediatr

PMID

28069410

Title

Dexamethasone and risk of bleeding in children undergoing tonsillectomy.

Year of Publication

2014

Number of Pages

872-9

Date Published

2014 May

ISSN Number

1097-6817

Abstract

<p><strong>OBJECTIVE: </strong>To determine whether dexamethasone use in children undergoing tonsillectomy is associated with increased risk of postoperative bleeding.</p>

<p><strong>STUDY DESIGN: </strong>Retrospective cohort study using a multihospital administrative database.</p>

<p><strong>SETTING: </strong>Thirty-six US children's hospitals.</p>

<p><strong>SUBJECTS: </strong>Children undergoing same-day tonsillectomy between the years 2004 and 2010.</p>

<p><strong>METHODS: </strong>We used discrete time failure models to estimate the daily hazards of revisits for bleeding (emergency department or hospital admission) up to 30 days after surgery as a function of dexamethasone use. Revisits were standardized for patient characteristics, antibiotic use, year of surgery, and hospital.</p>

<p><strong>RESULTS: </strong>Of 139,715 children who underwent same-day tonsillectomy, 97,242 (69.6%) received dexamethasone and 4182 (3.0%) had a 30-day revisit for bleeding. The 30-day cumulative standardized risk of revisits for bleeding was greater with dexamethasone use (3.11% vs 2.71%; standardized difference 0.40% [95% confidence interval, 0.13%-0.67%]; P = .003), and the increased risk was observed across all age strata. Dexamethasone use was associated with a higher standardized rate of revisits for bleeding in the postdischarge time periods of days 1 through 5 but not during the peak period for secondary bleeding, days 6 and 7.</p>

<p><strong>CONCLUSIONS: </strong>In a real-world practice setting, dexamethasone use was associated with a small absolute increased risk of revisits for bleeding. However, the upper bound of this risk increase does not cross published thresholds for a minimal clinically important difference. Given the benefits of dexamethasone in reducing postoperative nausea and vomiting and the larger body of evidence from trials, these results support guideline recommendations for the routine use of dexamethasone.</p>

DOI

10.1177/0194599814521555

Alternate Title

Otolaryngol Head Neck Surg

PMID

24493786

Title

Variation in quality of tonsillectomy perioperative care and revisit rates in children's hospitals.

Year of Publication

2014

Number of Pages

280-8

Date Published

2014 Feb

ISSN Number

1098-4275

Abstract

<p><strong>OBJECTIVE: </strong>To describe the quality of care for routine tonsillectomy at US children's hospitals.</p>

<p><strong>METHODS: </strong>We conducted a retrospective cohort study of low-risk children undergoing same-day tonsillectomy between 2004 and 2010 at 36 US children's hospitals that submit data to the Pediatric Health Information System Database. We assessed quality of care by measuring evidence-based processes suggested by national guidelines, perioperative dexamethasone and no antibiotic use, and outcomes, 30-day tonsillectomy-related revisits to hospital.</p>

<p><strong>RESULTS: </strong>Of 139,715 children who underwent same-day tonsillectomy, 10,868 (7.8%) had a 30-day revisit to hospital. There was significant variability in the administration of dexamethasone (median 76.2%, range 0.3%-98.8%) and antibiotics (median 16.3%, range 2.7%-92.6%) across hospitals. The most common reasons for revisits were bleeding (3.0%) and vomiting and dehydration (2.2%). Older age (10-18 vs 1-3 years) was associated with a greater standardized risk of revisits for bleeding and a lower standardized risk of revisits for vomiting and dehydration. After standardizing for differences in patients and year of surgery, there was significant variability (P &lt; .001) across hospitals in total revisits (median 7.8%, range 3.0%-12.6%), revisits for bleeding (median 3.0%, range 1.0%-8.8%), and revisits for vomiting and dehydration (median 1.9%, range 0.3%-4.4%).</p>

<p><strong>CONCLUSIONS: </strong>Substantial variation exists in the quality of care for routine tonsillectomy across US children's hospitals as measured by perioperative dexamethasone and antibiotic use and revisits to hospital. These data on evidence-based processes and relevant patient outcomes should be useful for hospitals' tonsillectomy quality improvement efforts.</p>

DOI

10.1542/peds.2013-1884

Alternate Title

Pediatrics

PMID

24446446

WATCH THIS PAGE

Subscription is not available for this page.